Start here if you're new
what it is
TriNet handles payroll, benefits, compliance, and HR admin for small and midsized businesses that do not want to screw up employment paperwork.
how it gets paid
Last year Trinet made $5.0B in revenue. health and insurance benefits was the main engine at $1.50B, or 30% of sales.
what just happened
TriNet reported -$0.02 EPS versus a -$0.28 estimate, but the business still has a client-count problem.
At a glance
B+ balance sheet — decent shape, but not bulletproof
60/100 earnings predictability — reasonably predictable
20.7x trailing p/e — priced about right
1.8% dividend yield — cash in your pocket every quarter
20.5% return on capital — every dollar works hard here
xvary composite: 65/100 — average
What they do
TriNet handles payroll, benefits, compliance, and HR admin for small and midsized businesses that do not want to screw up employment paperwork.
TriNet wins by bundling payroll, benefits, compliance, and HR software into one place. That matters when your business is too small to build an HR department, but too exposed to wing it. The company still earns a 20.5% return on capital, which is finance-speak for every $1 it puts into the business producing about $0.21 back, so the boring stuff is paying.
How they make money
$5.0B
annual revenue
health and insurance benefits
$1.50B
payroll administration
$1.25B
hr platform and employee records
$1.00B
risk and compliance services
$0.75B
recruiting and training tools
$0.50B
The products that matter
outsourced payroll, benefits, and compliance
PEO platform
$4.8B · 96% of revenue
This is the business. It produced $4.8B of TriNet's $5.0B revenue, and average worksite employee count fell 6% last quarter. Fewer covered employees usually means less revenue and less room to spread fixed costs.
client count matters
client-facing hr software layer
TriNet platform
no separate revenue disclosed
You interact with TriNet through software, but management does not break it out as its own revenue engine. In human-speak: the software supports the service model. It does not escape it.
service wrapper
insurance-related service revenue
Insurance services
$0.2B · 4% of revenue
At $0.2B, this piece is too small to carry the stock on its own. It helps around the edges, but TNET still rises and falls with the much larger PEO base.
too small to carry it
Key numbers
20.7x
trailing p/e
That is what you are paying today for a company whose EPS fell from $6.56 in 2023 to $2.90 in 2025.
20.5%
return on capital
Return on capital → profit earned on money invested → so what: TriNet still turns dull HR work into decent economics.
12.0%
operating margin
Operating margin → profit before interest and taxes → so what: the business has some cushion, but not a giant one.
$895M
long-term debt
That is 24% of capital, which is manageable but leaves less room if client counts keep sliding.
Financial health
B+
strength
- balance sheet grade B+ — solid but not elite
- risk rank 3 — safer than 50% of stocks
- price stability 50 / 100
- long-term debt $895M (24% of capital)
- net profit margin 3.3% — keeps 3 cents of every dollar in revenue
B+ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in TNET 3 years ago → it's now worth $9,380.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
TriNet reported -$0.02 EPS versus a -$0.28 estimate, but the business still has a client-count problem.
The beat came against a low bar. The clearer operating data was weaker: third-quarter revenue fell 2% vs. prior year to $1.12B, EPS dropped to $0.70 from $0.89, and average worksite employee count fell 6%.
$1.12B
revenue
$0.70
eps
12.0%
operating margin
the number that mattered
The 6% drop in average worksite employees matters most because fewer employees means fewer billing opportunities across payroll, benefits, and HR services.
-
trinet's third-quarter results were weak.
-
the top line fell 2% vs. prior year, to $1.12 billion, and the bottom line slipped to $0.70 per share, versus $0.89 in the year-ago period.
-
overall performance was pressured by a 6% decline in the average worksite employee (wse) count, weighed down by client attrition and muted hiring across the technology, professional services, main street, and life sciences groups.average wse change is an important metric for assessing the performance of the company's peo (professional employer organization) operations. profitability was further squeezed by higher rates paid for inpatient and professional services, along with rising pharmacy expenses tied to greater use of specialty drugs and other high-cost prescriptions, particularly medications for diabetes and obesity.
-
the bottom line will probably remain under pressure in the coming quarters.
-
this is probably, in part, due to increased expenses tied to the execution of its medium-term strategy, which includes process optimization, development of new offerings, and advancing go-to-market innovations.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
TriNet's biggest risk is worksite employee decline inside the PEO base. When covered employee count falls 6% and 96% of revenue comes from professional services, you are not dealing with a rounding error.
med
shrinking client base
Average worksite employee count fell 6% last quarter. That points to client losses, slower hiring, or both, and the core revenue line depends on those employees staying on the platform.
Impact: $4.8B of the company's $5.0B revenue sits in professional services, so continued WSE erosion pressures almost the entire business.
med
healthcare-cost inflation
Higher inpatient, professional-service, and pharmacy costs already squeezed results, with diabetes and obesity drugs called out directly. Thin margins make this a direct hit, not a footnote.
Impact: management's 7–8.5% adjusted EBITDA margin guide leaves little buffer if claims trends stay hot.
med
2026 guidance still proves too high
The company already told you revenue likely lands at $4.75–$4.90B and adjusted EPS at $3.70–$4.70. If employee counts worsen again, even that reduced bar may still miss reality.
Impact: on a 3.3% net margin, small revenue misses can move earnings fast and make the buyback look like defense instead of offense.
These are operating risks with numbers attached. They directly pressure a $4.8B core revenue stream, a 3.3% net margin, and a 2026 outlook already pointing below 2025.
source: institutional data · regulatory filings · risk analysis
Pay attention to
key metric
average worksite employee count
This is the first number to check next quarter. If the 6% decline starts narrowing, the revenue story gets less fragile. If it gets worse, the rest of the model probably follows.
cost pressure
healthcare claims and pharmacy trend
Management already flagged inpatient, professional-service, and specialty-drug inflation. On a 7–8.5% EBITDA margin, even modest medical-cost pressure matters.
calendar
next guidance update
The next earnings report should tell you whether $4.75–$4.90B of revenue and $3.70–$4.70 of adjusted EPS were conservative enough. Stability would help. Another cut would tell you the reset was not a one-quarter event.
capital return
buyback execution pace
A $400M authorization is meaningful against a roughly $3B market cap. If repurchases ramp while the stock stays near $60, EPS gets support. If execution stays slow, the headline matters more than the help.
Analyst rankings
earnings predictability
60 / 100
in human-speak, analysts view this as only moderately predictable — steady when hiring holds up, less steady when employee counts or medical costs move the wrong way.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 146 buyers vs. 118 sellers in 3q2025. total institutional holdings: 46.3M shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$45
$113
$60
current price
$79
target midpoint · +31% from current · 3-5yr high: $90 (+50% · 12% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive